Results 111 to 120 of about 22,884 (253)

Fear of Deportation and Latine Mental Health: A Rapid Review of Recent Literature

open access: yesJournal of Counseling &Development, Volume 104, Issue 3, Page 358-372, July 2026.
ABSTRACT Fear of deportation (FOD) remains a significant stressor for many in the Latine community, regardless of political climate. In recent years, intensified rhetoric and legislative actions have elevated immigration as a central US policy issue, increasing concern about related mental health needs.
Daniel Gutierrez, Nicole Silverio
wiley   +1 more source

A cost-based-plus pricing approach for repurposed tiratricol in the treatment of Allan-Herndon-Dudley syndrome. [PDF]

open access: yesOrphanet J Rare Dis
Manders E   +5 more
europepmc   +1 more source

CAR‐T Cells in Ulcerative Colitis: The Renaissance of B‐Cell Targeted Therapy in UC

open access: yesJCC Plus, Volume 1, Issue 4, July 2026.
ABSTRACT A recent New England Journal of Medicine report described the first successful use of anti‐CD19 CAR‐T cell therapy in a patient with multirefractory ulcerative colitis (UC). This exceptional case provides striking proof of concept that B cells and plasma cells can act as key pathogenic drivers in UC.
Zlata Chkolnaia   +2 more
wiley   +1 more source

Use of Real-World Evidence in Health Technology Assessments of Non-Oncology Rare Disease Therapies. [PDF]

open access: yesJ Mark Access Health Policy
Blandy O   +5 more
europepmc   +1 more source

Mass spectrometry proteomics for studying mitostasis

open access: yesProtein Science, Volume 35, Issue 7, July 2026.
Abstract Maintaining mitochondrial integrity and function is fundamental to cellular homeostasis. Cells rely on coordinated protein quality control (QC) systems—including intricate chaperone‐protease networks, the ubiquitin‐proteasome system, and cytosolic surveillance pathways—that together form a dynamic, cell‐wide mitostasis network governing the ...
Lakshita Sharma   +5 more
wiley   +1 more source

Milestones On Orphan Medicinal Products Development: The 100 First Drugs for Rare Diseases Approved Throughout Europe [PDF]

open access: yesClinical Therapeutics, 2015
C. Pontes   +8 more
openaire   +2 more sources

Evidence for a Two‐Step Model for Activation of GPR25 by the Chemoattractant CXCL17

open access: yesBasic &Clinical Pharmacology &Toxicology, Volume 139, Issue 1, July 2026.
ABSTRACT CXCL17 was recently reported to activate GPR25, a receptor expressed by T‐regulatory cells. Although classified as a chemokine, the activity of CXCL17 is ablated by minor C‐terminal truncation, suggesting a novel mode of receptor activation. We set out to test this hypothesis by mutagenesis. GPR25 was expressed in the murine pre‐B cell line L1.
Wuqing Yang   +2 more
wiley   +1 more source

Medicine Development and Access for Rare Diseases: Can We Do Better? [PDF]

open access: yesJ Inherit Metab Dis
Hollak CEM   +14 more
europepmc   +1 more source

Drugst.One DREAM—Drug repurposing through expert annotation and modification

open access: yesBritish Journal of Pharmacology, Volume 183, Issue 13, Page 3503-3516, July 2026.
Background and Purpose Complex diseases often lack an actionable understanding of their underlying causal biological mechanisms, which leads to treating symptoms rather than causes. Network and systems medicine define disease mechanisms through disease‐associated genes, their encoded proteins and their protein–protein interactions (PPIs), thus forming ...
Lisa M. Spindler   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy